FOX04-DRI
Caution, BioHarmony verdict
BioHarmony score 4.1 out of 10
FOXO4-DRI is a designed senolytic peptide that kills senescent cells by breaking the FOXO4 to p53 bond, famous for restoring fur and kidney function in aged mice per Baar 2017. It has zero human trials, no registered study, and grey-market-only sourcing, so it scores 4.0-4.5/10 in Caution.
Read full reportWhat is FOX04-DRI?
FOXO4-DRI is a designed senolytic peptide that kills senescent cells by breaking the bond between the protein FOXO4 and the tumor suppressor p53, and it scores 4.0-4.5/10 in Caution for one blunt reason: it is one of the most hyped longevity peptides on the market and it has zero human evidence. The mechanism is genuinely clever and the preclinical result is striking, but every bit of that result is in mice or cell culture, led by a single 2017 study in Cell, per Baar 2017.
From the BioHarmony report, reviewed Sep 19, 2026.
Saved on this device only.
How it is thought to work
Senolysis: displaces FOXO4 from p53 to push senescent cells into apoptosis
Safety watch-outs
- Any active or suspected cancer: do not use, since broad p53 and apoptosis modulation in an uncharacterized peptide is exactly the wrong…
- Fever, spreading redness, or pus at an injection site (possible infection from non-sterile research-chemical product): stop and seek…
- Any unexplained systemic reaction after injection of an unapproved grey-market peptide: stop and consult a clinician.
Full risk profile in the BioHarmony report.
Dosing as published
Source-reported figures only. This page does not calculate a personal dose.
No approved-label or study protocol is recorded for FOX04-DRI yet.
More reported protocols
MembersMembers can compare additional reported doses, schedules, and preparation notes.
Educator coverage (2)
Attributed viewpoints, separate from primary research.
- FOXO4-DRI: A Senolytic Peptide for Clearing Senescent Cells Hunter Williams,
- FOXO4-DRI Peptide Benefits, Dosage & Side Effects Jay Campbell,
Trust & sourcing
- Last revieweddone
- Next reviewupcoming
FOXO4-DRI remains preclinical. Published studies report senescent-cell effects in cell and mouse models; they do not establish human safety, effectiveness, or dosing.
Primary sources
Related peptides for longevity & cellular
- 6.6ThymulinThymulin (zinc-thymulin) is a chemically defined, zinc-dependent thymic nonapeptide hormone with deep classical immunology behind it but no modern human trial of the…
- 5.9ThymalinThymalin is a bovine-thymus peptide extract studied for immune restoration and aging.
- 5.7VilonVilon is the Lysine-Glutamic acid (KE) dipeptide from Vladimir Khavinson's bioregulator program, sold for immune restoration and anti-aging.
- 7.2GHK-Cu (Copper Peptide)GHK-Cu is a human copper-binding tripeptide with the best evidence for topical skin repair and wound healing, including Mulder 1994 diabetic ulcer data showing 98.5%…
The Ultimate Peptides Guide
Spot stronger candidates, weak evidence, and seller red flags before you buy.